Synlett 2019; 30(10): 1228-1230
DOI: 10.1055/s-0037-1611553
letter
© Georg Thieme Verlag Stuttgart · New York

Asymmetric Synthesis of cis-(S,R)-3-Amino-4-fluoro-1-methylpyrrolidine

Zhongbo Fei
a   Chemical and Analytical Development, Suzhou Novartis Pharma Technology Co., Ltd, Changshu, Jiangsu 215537, P. R. of China   Email: jianwei.bian@novartis.com
,
Xin Xiong
a   Chemical and Analytical Development, Suzhou Novartis Pharma Technology Co., Ltd, Changshu, Jiangsu 215537, P. R. of China   Email: jianwei.bian@novartis.com
,
Chiming Cheung
a   Chemical and Analytical Development, Suzhou Novartis Pharma Technology Co., Ltd, Changshu, Jiangsu 215537, P. R. of China   Email: jianwei.bian@novartis.com
,
Weipeng Liu
a   Chemical and Analytical Development, Suzhou Novartis Pharma Technology Co., Ltd, Changshu, Jiangsu 215537, P. R. of China   Email: jianwei.bian@novartis.com
,
Qirong Shen
b   Zhejiang Jiuzhou Pharmaceutical Technology Co., Ltd., Jiangling Road 88, Binjiang, Hangzhou, Zhejiang 310000, P. R. of China
,
Jinzhu Zhang
b   Zhejiang Jiuzhou Pharmaceutical Technology Co., Ltd., Jiangling Road 88, Binjiang, Hangzhou, Zhejiang 310000, P. R. of China
,
Hongjun Gao
b   Zhejiang Jiuzhou Pharmaceutical Technology Co., Ltd., Jiangling Road 88, Binjiang, Hangzhou, Zhejiang 310000, P. R. of China
,
Jianwei Bian*
a   Chemical and Analytical Development, Suzhou Novartis Pharma Technology Co., Ltd, Changshu, Jiangsu 215537, P. R. of China   Email: jianwei.bian@novartis.com
› Author Affiliations
All work described in this paper was funded by Novartis, Inc.
Further Information

Publication History

Received: 14 March 2019

Accepted after revision: 30 April 2019

Publication Date:
20 May 2019 (online)


Abstract

The development of the stereoselective synthesis of cis-(S,R)-3-amino-4-fluoro-1-methylpyrrolidine is described starting from chiral, non-racemic 1-[(3S,4S)-3-azido-4-hydroxypyrrolidin-1-yl]-2,2,2-trifluoroethan-1-one. Two sets of deoxyfluorination conditions are developed for achieving inversion of the chiral center with high or complete stereoselectivity.

Supporting Information

 
  • References and Notes

    • 1a Coleman PJ, Cox CD. WO 2005017190, 2005
    • 1b Kawato H, Miyazaki M, Sugimoto Y, Naito H, Okayama T, Soga T, Uoto K. WO 2008072655, 2008
    • 1c Corminboeuf O, Pozzi D. WO 2013171694, 2013
    • 1d Guerin DJ, Bair KW, Caravella JA, Ioannidis S, Lancia DR. Jr, Li H, Mischke S, Ng PY, Richard D, Schiller SE. R, Shelekhin T, Wang Z. WO 2017139778, 2017
  • 3 Tsuzuki Y, Chiba K, Mizuno K, Tomita K, Suzuki K. Tetrahedron: Asymmetry 2001; 12: 2989
  • 5 Beckmann HS. G, Wittmann V. In Organic Azides: Syntheses and Applications . Bräse S, Banert K. John Wiley & Sons; Chichester: 2010: 469-490
  • 6 Lewis ES, Boozer CE. J. Am. Chem. Soc. 1952; 74: 308
  • 7 Cram DJ. J. Am. Chem. Soc. 1953; 75: 332
  • 8 Ishii A, Yasumoto M. WO 2010047266, 2010
  • 9 Cismesia MA, Ryan SJ, Bland DC, Sanford MS. J. Org. Chem. 2017; 82: 5020
  • 10 Characterization of 1. Yield: 99 mg (94%); white solid; mp 264–266 °C. 1H NMR (400 MHz, D2O): δ = 5.55 (dt, J = 51.7, 3.5 Hz, 1 H), 4.36 (dtd, J = 23.4, 8.9, 3.5 Hz, 1 H), 4.01 (m, 1 H), 3.88 (m, 1 H), 3.82–3.52 (m, 2 H), 3.00 (s, 3 H). 13C NMR (101 MHz, D2O): δ = 90.4 (d, J = 183.82 Hz), 59.6 (d, J = 21.21 Hz), 54.4, 50.3 (d, J = 17.17 Hz), 42.6. 19F NMR (376 MHz, D2O): δ = –196.7. 19F NMR (376 MHz, CD3OD): δ = –198.1. HRMS (ESI): m/z [M + H – 2 HCl]+ calcd for C5H12FN2: 119.0979; found: 119.0978.